|
|
 |
NewCan Biotech Limited
|
|
|
| |
|
|
NewCan Biotech Limited was established in 2021 and is primarily engaged in the research, development, production, and sales of
sugars, nucleosides, nucleotides, phosphorylated monomers, as well as next-generation antiviral and antitumor drug intermediates.
Our products are mainly used in new drug development, biocatalysis, PCR amplification, gene sequencing, diagnostic reagent production, and life science research. We have comprehensive laboratory, analysis, and production facilities equipped with a professional research and development team, enabling us to scale from
small-scale trials and pilot studies to industrial production.
As a leading company in the field, we are committed to providing high-quality raw materials and products to meet the needs of the pharmaceutical, biotechnology,
and life science industries.
|
[ Selling Categories ]
|
[ keyword ]
|
Registration Date |
2025/06/17 (Year/Month/Date) |
Buyer / Seller in EC21 |
Seller |
Business Type |
Manufacturer |
Year established |
2021 |
Employees total |
6 - 10 |
Annual revenue |
USD 100,000 - 500,000 |
|
Contact Information |
 |
|
Company |
NewCan Biotech Limited |
Address |
No. 99, Wangzhou Road, Liangzhu Street, Yuhang District Hangzhou Zhejiang 311113 China |
Phone |
86 - 0571 - 86912261 |
Homepage |
www.newcanbio.com |
Contact |
Chen
|
|
|
|
| |
|
|
|